We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Paris to Host International Biology Days

By HospiMedica staff writers
Posted on 13 Sep 2005
Paris (France) will host the 50th anniversary of the International Biology Days (JIB, Journees Internationales de Biologie) from November 3-5, 2005. More...
More than 8,000 visited the event in 2004, which had foreign participation of 15% and 147 exhibitors.

Biomedical engineers, laboratory assistants, and technicians convene to learn about the latest developments in their profession and the impact of new technologies on their specialty. On this jubilee anniversary, there will be a retrospective exhibition of devices that illustrate 50 years of technologic progress in medical biology. It all began in 1953 as a training day on medical analyses for interested pharmacists and then grew into the most important annual assembly of clinical biologists in Europe. Italy will be honored this year for its proactive approach of advancement and interchange with other European countries. For the first time, part of the scientific program will be held in English.

The conference will open with a session on oxidative stress markers. Other sessions will deal with proteomics, allergy research, standardized specifications of laboratory analyzers, and dosage of carotenoids. The second part of the program will highlight the diagnostic approach in mycology, the threat of multi-resistant bacteria, anticoagulation treatment clinics, the place of liquid-based smear in cervix testing, and the detection of the Papilloma virus by polymerase chain reaction (PCR) in cervical cancer screening. The Café Scientifique, a forum for the exchange of views on current topics, will enhance dialogues between specialists and professionals on themes of interest and topics related to biology.

The conference is sponsored by the Societe Francaise de Biologie Clinique (SFBC) and the Institute of Health and Medical Research (INSERM, Paris, France). Further details on the conference are available on the JIB website.




Related Links:
JIB

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.